Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer ; volume:18 ; number:1 ; day:10 ; month:12 ; year:2018 ; pages:1-12 ; date:12.2018
BMC cancer ; 18, Heft 1 (10.12.2018), 1-12, 12.2018
- Creator
-
Kim, Soochi
Lee, Maria
Dhanasekaran, Danny N.
Song, Yong Sang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-5152-5
- URN
-
urn:nbn:de:101:1-2019012800020610169031
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Soochi
- Lee, Maria
- Dhanasekaran, Danny N.
- Song, Yong Sang
- SpringerLink (Online service)
Other Objects (12)
Management of non-ovarian cancer malignant ascites through indwelling catheter drainage
Peritoneal carcinomatosis and malignant ascites
Ovarian hyperstimulation syndrome and pregnancy luteoma mimicking malignant ascites: a rare case report
Tumor evolution and chemoresistance in ovarian cancer
Deciphering the ovarian cancer ascites fluid peptidome
Disaggregation and invasion of ovarian carcinoma ascites spheroids
Cervical Esophago-Gastric Tubes for Patients with Malignant Ascites
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma
Perspectives In Malignant Ovarian Tumours
Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Management of non-ovarian cancer malignant ascites through indwelling catheter drainage
Peritoneal carcinomatosis and malignant ascites
Ovarian hyperstimulation syndrome and pregnancy luteoma mimicking malignant ascites: a rare case report
Tumor evolution and chemoresistance in ovarian cancer
Deciphering the ovarian cancer ascites fluid peptidome
Disaggregation and invasion of ovarian carcinoma ascites spheroids
Cervical Esophago-Gastric Tubes for Patients with Malignant Ascites
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma
Perspectives In Malignant Ovarian Tumours
Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Management of non-ovarian cancer malignant ascites through indwelling catheter drainage
Peritoneal carcinomatosis and malignant ascites
Ovarian hyperstimulation syndrome and pregnancy luteoma mimicking malignant ascites: a rare case report
Tumor evolution and chemoresistance in ovarian cancer
Deciphering the ovarian cancer ascites fluid peptidome
Disaggregation and invasion of ovarian carcinoma ascites spheroids
Cervical Esophago-Gastric Tubes for Patients with Malignant Ascites
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma
Perspectives In Malignant Ovarian Tumours
Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience